Influenza vaccine nasal vaccination system
A flu vaccine, transnasal technology, applied in the direction of antibody medical ingredients, inorganic non-active ingredients, aerosol delivery, etc., to achieve strong immune induction, less side effects, and maintain antigenicity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example 1
[0087]
[0088]
[0089] Virus stock solution example 1
[0090]
[0091] Virus stock solution example 2
[0092]
[0093]
[0094] Virus stock solution example 3
[0095]
[0096]
[0097] Each of the above-mentioned colloidal base example (1) and virus stock solution examples (1)-(3) is stirred and mixed at a ratio of 1:1, respectively, to prepare homogeneous influenza vaccine composition example 1 and example 2. and Example 3. The composition of the composition of each example and its physical properties / spray performance exhibited when sprayed using a spray device or a syringe-type sprayer are shown below. The stirring and mixing process can be done gently in a short time without stressing the inactivated whole virus antigen. In the resulting influenza vaccine composition, the amounts of the respective components and the spraying properties exhibited by spraying the composition using an appropriate device are shown below.
[0098] Example 1 ...
example 2
[0101]
example 3
[0103]
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com